Erik Kelly

734 total citations
10 papers, 299 citations indexed

About

Erik Kelly is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, Erik Kelly has authored 10 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 1 paper in Infectious Diseases. Recurrent topics in Erik Kelly's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Erik Kelly is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Erik Kelly collaborates with scholars based in United States and United Kingdom. Erik Kelly's co-authors include Catherine E. Kerr, Anthony Lembo, Lisa Conboy, Ted J. Kaptchuk, Eric Jacobson, Anna Legedza, Sun Myeong Ock, William B. Stason, Katia M. Canenguez and Linda Hemphill and has published in prestigious journals such as The American Journal of the Medical Sciences, Neurogastroenterology & Motility and Circulation Cardiovascular Interventions.

In The Last Decade

Erik Kelly

8 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Kelly United States	7	152	85	83	80	59	10	299
Adrienne Lenhart United States	10	177 1.2×	20 0.2×	19 0.2×	89 1.1×	87 1.5×	22	455
Andrew Feld United States	8	187 1.2×	10 0.1×	53 0.6×	45 0.6×	51 0.9×	14	337
Pia Agerforz Sweden	6	319 2.1×	18 0.2×	35 0.4×	141 1.8×	69 1.2×	12	382
S. Pintov Israel	6	39 0.3×	34 0.4×	132 1.6×	80 1.0×	56 0.9×	8	346
Luke J.D. O'Donnell United Kingdom	5	312 2.1×	12 0.1×	34 0.4×	161 2.0×	111 1.9×	9	453
Daniel P. McKee United States	7	206 1.4×	12 0.1×	39 0.5×	79 1.0×	52 0.9×	10	368
D. Kumar United Kingdom	6	245 1.6×	15 0.2×	24 0.3×	87 1.1×	82 1.4×	8	365
Teodora Surdea‐Blaga Romania	11	314 2.1×	14 0.2×	26 0.3×	194 2.4×	81 1.4×	39	462
Adriana Lazarescu Canada	10	296 1.9×	10 0.1×	25 0.3×	261 3.3×	74 1.3×	23	438
Ann E. Almazar United States	10	378 2.5×	14 0.2×	39 0.5×	222 2.8×	114 1.9×	19	438

Countries citing papers authored by Erik Kelly

Since Specialization

Citations

This map shows the geographic impact of Erik Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Kelly more than expected).

Fields of papers citing papers by Erik Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Kelly. The network helps show where Erik Kelly may publish in the future.

Co-authorship network of co-authors of Erik Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Kelly. A scholar is included among the top collaborators of Erik Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Kelly. Erik Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Badri, Marwan, et al.. (2024). Case report: dyslipidaemia—dramatic increase in haemoglobin A1c following statin initiation. European Heart Journal - Case Reports. 8(8). ytae436–ytae436.

2.

Belanger, Matthew J., Erik Kelly, Usman A. Tahir, & Mark D. Benson. (2021). Genetic Risk Assessment for Atherosclerotic Cardiovascular Disease: A Guide for the General Cardiologist. Cardiology in Review. 30(4). 206–213. 2 indexed citations

3.

Kelly, Erik, et al.. (2021). MITOCHONDRIAL DISEASES. Neuromuscular Disorders. 31. S114–S115.

4.

Kelly, Erik & Duane S. Pinto. (2019). Invasive Management of Out of Hospital Cardiac Arrest. Circulation Cardiovascular Interventions. 12(9). e006071–e006071. 7 indexed citations

5.

Kelly, Erik & Linda Hemphill. (2017). Lipoprotein(a): A Lipoprotein Whose Time Has Come. Current Treatment Options in Cardiovascular Medicine. 19(7). 48–48. 14 indexed citations

6.

Manian, Farrin A. & Erik Kelly. (2016). Lower Extremity Acute Bacterial Skin and Soft Tissue Infection Following Total Knee Arthroplasty. The American Journal of the Medical Sciences. 352(2). 154–158. 6 indexed citations

7.

Kelly, Erik, et al.. (2015). Targeting Lipoprotein (a): an Evolving Therapeutic Landscape. Current Atherosclerosis Reports. 17(5). 502–502. 9 indexed citations

8.

Duffy, Danielle, et al.. (2014). Aspirin for Cardioprotection and Strategies to Improve Patient Adherence. Postgraduate Medicine. 126(1). 18–28. 15 indexed citations

9.

Stason, William B., Anna Legedza, Sun Myeong Ock, et al.. (2005). The placebo effect in irritable bowel syndrome trials: a meta‐analysis¹. Neurogastroenterology & Motility. 17(3). 332–340. 240 indexed citations

10.

Boyd, Eldon M., et al.. (1956). Lipid and water levels in five organs of albino rats bearing Walker carcinosarcoma 256.. PubMed. 16(6). 535–43. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact